J-Pharma
Latest round
- Series F
Last raised
- Jul 2025
Total raised
- $67M
Investors
- 28
About J-Pharma
a. J-Pharma, specializes in pharmaceutical development, focusing on SLC transporters to facilitate drug discovery.24 million shares at JPY 880 per share at the Tokyo Stock Exchange, Growth market.69 billion. J-Pharma specializes in the development of innovative pharmaceuticals targeting SLC transporters, particularly focusing on LAT1 (L-type amino acid transporter), which was discovered by the company's founder. The firm engages in the identification and analysis of promising transporters to facilitate drug discovery aimed at addressing unmet medical needs. Their core product offerings include an array of compounds in various stages of development targeting diseases with significant medical gaps, such as certain cancers. The end users primarily encompass healthcare providers and patients suffering from these conditions, with particular emphasis on therapeutic solutions that enhance patient health and wellbeing.J-Pharma generates revenue through partnerships and collaborations with hospitals, research institutions, and other pharmaceutical companies, focusing on B2B transactions. The company’s transactions are structured around collaborative research agreements and clinical trial partnerships, allowing it to leverage resources and expertise for drug development. These partnerships often involve shared costs and co-development of proprietary drugs, which are positioned for commercialization following successful clinical trials. The company's flagship product, an LAT1 inhibitor named "Nanblanrat," is currently undergoing clinical trials with the potential for future sales following regulatory approvals. Specific pricing plans and transaction details are not publicly disclosed, as J-Pharma's focus remains on advancing its pipeline and addressing crucial therapeutic needs.
Who invested in J-Pharma
28 investors across 8 rounds
See all investors in J-Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Jul 7, 2025
Amount
$3.3M
Investors
Series E
Apr 1, 2025
Amount
$25M
Investors
Series E
Oct 5, 2023
Amount
$6.2M
Investors
Series D
Jul 30, 2021
Amount
$5.5M
Investors
Series D
Jan 7, 2021
Amount
$4.8M
Investors
Series D
Jul 30, 2020
Amount
$14M
Investors
Series C
Aug 27, 2019
Amount
$6.7M
Investors
Series A
Apr 9, 2018
Amount
$0.9M
Investors
Questions about J-Pharma
Who invested in J-Pharma?
J-Pharma has 28 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has J-Pharma raised?
J-Pharma has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did J-Pharma last raise money?
J-Pharma's most recent round on record is a Series F, in Jul 2025.
What does J-Pharma do?
J-Pharma is a pharmaceuticals company.
Where is J-Pharma headquartered?
J-Pharma is headquartered in Tokyo, Japan.
Which VCs invest in companies like J-Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at J-Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series F
Raising like J-Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.